Effect of farnesol on Staphylococcus aureus biofilm formation and antimicrobial susceptibility
about
Polymicrobial community-acquired pneumonia: An emerging entityGenetic control of bacterial biofilmsSystemic Staphylococcus aureus infection mediated by Candida albicans hyphal invasion of mucosal tissue.Antibacterial Activity of Euphorbia hebecarpa Alcoholic Extracts Against Six Human Pathogenic Bacteria in Planktonic and Biofilm FormsBiofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics.Farnesol induces apoptosis and oxidative stress in the fungal pathogen Penicillium expansum.Clinical results of linezolid in arthroplasty and trauma MRSA related infections.Impact of Staphylococcus aureus on pathogenesis in polymicrobial infections.Printed paper-based arrays as substrates for biofilm formation.nBioChip, a Lab-on-a-Chip Platform of Mono- and Polymicrobial Biofilms for High-Throughput Downstream Applications.Effect of farnesol on structure and composition of Staphylococcus epidermidis biofilm matrix.Quorum sensing in fungi: Q&A.Possible inhibitory molecular mechanism of farnesol on the development of fluconazole resistance in Candida albicans biofilm.Farnesol-induced apoptosis in Candida albicans is mediated by Cdr1-p extrusion and depletion of intracellular glutathione.Confocal laser scanning microscopy analysis of S. epidermidis biofilms exposed to farnesol, vancomycin and rifampicin.Fungal biofilms, drug resistance, and recurrent infectionR-thanatin inhibits growth and biofilm formation of methicillin-resistant Staphylococcus epidermidis in vivo and in vitro.Characterization of genetic determinants that modulate Candida albicans filamentation in the presence of bacteriaIn vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms.N-terminally modified linear and branched spermine backbone dipeptidomimetics against planktonic and sessile methicillin-resistant Staphylococcus aureus.Communication in fungipH-activated nanoparticles for controlled topical delivery of farnesol to disrupt oral biofilm virulence.Farnesol decreases biofilms of Staphylococcus epidermidis and exhibits synergy with nafcillin and vancomycinPluronics-Formulated Farnesol Promotes Efficient Killing and Demonstrates Novel Interactions with Streptococcus mutans Biofilms.Prostaglandin E2 from Candida albicans Stimulates the Growth of Staphylococcus aureus in Mixed Biofilms.Elucidating the molecular physiology of lantibiotic NAI-107 production in Microbispora ATCC-PTA-5024.Go Forth and Colonize: Dispersal from Clinically Important Microbial Biofilms.Coral-Associated Bacteria as a Promising Antibiofilm Agent against Methicillin-Resistant and -Susceptible Staphylococcus aureus Biofilms.In vitro inhibitory effects of farnesol and interactions between farnesol and antifungals against biofilms of Candida albicans resistant strains.Impact of a Cross-Kingdom Signaling Molecule of Candida albicans on Acinetobacter baumannii PhysiologyEffect of farnesol on growth, ergosterol biosynthesis, and cell permeability in Coccidioides posadasii.Candida albicans Airway Colonization Facilitates Subsequent Acinetobacter baumannii Pneumonia in a Rat Model.Efficacy of Linezolid and Fosfomycin in Catheter-Related Biofilm Infection Caused by Methicillin-Resistant Staphylococcus aureus.Commensal Protection of Staphylococcus aureus against Antimicrobials by Candida albicans Biofilm Matrix.A rapid molecular method for characterising bacterial bioburden in chronic wounds.Microbial quorum-sensing molecules induce acrosome loss and cell death in human spermatozoa.Cross-kingdom interactions: Candida albicans and bacteria.Cellular interactions of farnesol, a quorum-sensing molecule produced by Candida albicans.Candida species in cystic fibrosis: A road less travelled.Genetic control of Candida albicans biofilm development
P2860
Q26780356-9596506C-DD47-40D4-8AA5-1527390A5B26Q26796226-A533152C-8A9B-4678-89B0-649196BC7548Q27323146-1A683FBD-8743-40C3-9819-BE30B8AC31FAQ28831289-6799D555-AD1D-4745-B6B4-0A720C870A8BQ30403958-AE1D671C-5478-4896-8D91-0644BE47ABEEQ30980248-C98337B3-E713-49CC-87EF-D275195E9155Q33595823-8EFCCD47-CCA4-4517-B479-5822D4E608E7Q33602984-6A200588-0D86-4138-B712-0EEC4A45B8AEQ33830404-4CE645F1-D32D-4F4C-925D-69DFB32AA474Q33849725-8B347BE0-46ED-4003-A489-08D83D07F002Q33975065-1258EC76-8790-43AA-8FB8-F5B2C4E92904Q34064190-39C9A7C7-DF72-4937-B28B-A880715B38E5Q34079974-2137D871-DD9C-434E-9B03-2F161B35C5F6Q34113632-D3280731-C77B-423F-B149-8B95068C2332Q34271793-36D46189-886C-43BE-B040-E092A8923240Q34355341-DAFDCEF4-7E1C-401C-96A4-6EB67ED6C11FQ34896647-7888CDD0-39F0-4D40-8C86-56F916795599Q34950943-D7BE602C-51C1-4988-885F-944E91AE5703Q35152853-2BD1E962-D13C-45C9-88C7-AA311192C87AQ35198896-C67413E3-036F-4982-A052-8EC755F3B02FQ35233999-2EF3BEB0-3AB2-426F-BE0F-B4F60CE277DBQ35394505-656D550E-63EF-40A0-AE6C-EE18FA3CA47AQ35535689-E69173E0-F509-40F6-BFA4-8527FD2EA81BQ35723178-47D0F5CE-4946-49F8-811E-41BD13D9A26AQ35742511-A0EB66C6-6B61-4D08-B7F5-7EBE0EA02EE6Q35891264-6E672C74-76F5-4B22-840A-3C85A706531FQ35927449-CF27FF2A-51AA-45E0-BA73-E5199760EB99Q36228787-426536D3-78FD-4E30-B67E-4E3478F69D3AQ36314153-42925E19-760F-4E13-BD5C-D1C744E67233Q36439189-5EADE015-CD53-4376-B580-BE89EAE2BBDEQ36785890-DA0A4CF7-B14C-4F0F-AC7C-020875DBD13AQ36933454-C3A4D864-C8A4-4E18-917F-4E4888A87109Q37018700-B5F8CD3A-BC7C-4A7B-8CDA-34DFB7D27AC1Q37335095-0F08D7EC-6917-46F1-835C-7FF748B45BB7Q37340283-A7EAE24B-4BF1-49A1-A9DB-6024F1F86ADAQ37410289-369D354D-8C3F-4F43-9C24-AF38D8C6BAB8Q37529923-E2EE71C8-BC29-4DEA-9490-567D4D17CCC4Q37648725-45713E31-060A-4580-82D8-022667014999Q37808468-69FCC3DE-ACD3-4839-86CF-2BF90FFE982CQ37824380-AFE83838-CA02-40BB-B3EC-E14AA81EF22C
P2860
Effect of farnesol on Staphylococcus aureus biofilm formation and antimicrobial susceptibility
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Effect of farnesol on Staphylo ...... d antimicrobial susceptibility
@ast
Effect of farnesol on Staphylo ...... d antimicrobial susceptibility
@en
Effect of farnesol on Staphylo ...... d antimicrobial susceptibility
@nl
type
label
Effect of farnesol on Staphylo ...... d antimicrobial susceptibility
@ast
Effect of farnesol on Staphylo ...... d antimicrobial susceptibility
@en
Effect of farnesol on Staphylo ...... d antimicrobial susceptibility
@nl
prefLabel
Effect of farnesol on Staphylo ...... d antimicrobial susceptibility
@ast
Effect of farnesol on Staphylo ...... d antimicrobial susceptibility
@en
Effect of farnesol on Staphylo ...... d antimicrobial susceptibility
@nl
P2093
P2860
P1476
Effect of farnesol on Staphylo ...... d antimicrobial susceptibility
@en
P2093
M A Jabra-Rizk
M E Shirtliff
T F Meiller
P2860
P304
P356
10.1128/AAC.50.4.1463-1469.2006
P407
P577
2006-04-01T00:00:00Z